Aziyo Biologics

About

Aziyo is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.

Silver Spring,Maryland,United States
101 - 250
http://aziyo.com

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $11.20M
Industries: Biotechnology,Health Care,Medical
Founded date: Jan 1, 2015
Number Of Employee: 101 - 250
Operating Status: Active
Stock Symbol: nasdaq:AZYO
Legal Name: Aziyo Biologics, Inc.

Aziyo is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. From our proprietary tissue processing platforms, we have developed a portfolio of advanced regenerative medical products that are designed to be very similar to natural biological material.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

8

$109.28M

Aziyo Biologics has raised a total of $109.28M in funding over 2 rounds. Their latest funding was raised on Dec 15, 2022 from a Post-IPO Debt round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 15, 2022	Post-IPO Debt	$4M	1	SWK Holdings	—	Detail
Dec 1, 2022	Post-IPO Equity	$11.20M	—	—	—	Detail
Dec 6, 2021	Post-IPO Equity	$14M	—	—	—	Detail
Oct 8, 2020	IPO	$50M	—	—	—	Detail
Sep 11, 2020	Series Unknown	$5.03M	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

5

0

Aziyo Biologics has made 5 investments. Their most recent investment was on Nov 16, 2022, when Virtualness raised $8M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Nov 16, 2022 Virtualness	Seed	$8M	Information Technology	—
May 16, 2022 Smytten	Series B	₹1B	Consumer	—
May 11, 2022 GoKwik	Series B	$35M	Artificial Intelligence	—
Feb 22, 2022 Slurrp Farm	Series Unknown	₹520M	Food and Beverage	—
Oct 9, 2019 Smytten	Series A	$1.50M	Consumer	—